These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3948173)

  • 1. Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products.
    Davidson NE; Bronzert DA; Chambon P; Gelmann EP; Lippman ME
    Cancer Res; 1986 Apr; 46(4 Pt 2):1904-8. PubMed ID: 3948173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer.
    Lippman ME; Bates S; Huff KK; Davidson N; Dickson RB
    J Lab Clin Med; 1987 Mar; 109(3):230-5. PubMed ID: 3469292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
    Johnson MR; Valentine C; Basilico C; Mansukhani A
    Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells.
    Aitken SC; Lippman ME; Kasid A; Schoenberg DR
    Cancer Res; 1985 Jun; 45(6):2608-15. PubMed ID: 3986799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
    Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB
    Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW; Horan AD; Chen Y; Weigel RJ
    Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dietary supplement for female sexual dysfunction, Avlimil, stimulates the growth of estrogen-dependent breast tumors (MCF-7) implanted in ovariectomized athymic nude mice.
    Ju YH; Doerge DR; Helferich WG
    Food Chem Toxicol; 2008 Jan; 46(1):310-20. PubMed ID: 17919800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen inhibition of a Mr 39,000 glycoprotein secreted by human breast cancer cells.
    Bronzert D; Silverman S; Lippman M
    Cancer Res; 1987 Mar; 47(5):1234-8. PubMed ID: 3815334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-induced proteins in estrogen-sensitive cells.
    Iacobelli S; Natoli V; Scambia G
    Prog Clin Biol Res; 1984; 142():53-62. PubMed ID: 6709660
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
    Kida N; Yoshimura T; Mori K; Hayashi K
    Cancer Res; 1989 Jul; 49(13):3494-8. PubMed ID: 2731170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast cancer and its hormonal dependency].
    Matsumoto K; Sato B
    Gan No Rinsho; 1989 May; Spec No():204-11. PubMed ID: 2689662
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of estrogen receptor expression.
    Martin MB; Saceda M; Garcia-Morales P; Gottardis MM
    Breast Cancer Res Treat; 1994; 31(2-3):183-9. PubMed ID: 7881098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.